Compare IRON & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | VC |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | 10000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | 2020 | 2000 |
| Metric | IRON | VC |
|---|---|---|
| Price | $74.14 | $107.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | $103.18 | ★ $125.50 |
| AVG Volume (30 Days) | 560.7K | ★ 572.9K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.93 |
| Revenue | N/A | ★ $3,768,000,000.00 |
| Revenue This Year | N/A | $2.39 |
| Revenue Next Year | $283.52 | $5.21 |
| P/E Ratio | ★ N/A | $36.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.00 | $83.49 |
| 52 Week High | $99.50 | $128.32 |
| Indicator | IRON | VC |
|---|---|---|
| Relative Strength Index (RSI) | 48.24 | 51.78 |
| Support Level | $70.29 | $103.46 |
| Resistance Level | $82.65 | $117.46 |
| Average True Range (ATR) | 3.37 | 4.16 |
| MACD | -0.51 | 0.55 |
| Stochastic Oscillator | 19.25 | 88.26 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America.